Dong M. Shin, MD, FACP
Professor of Hematology, Oncology, and Otolaryngology; Associate Director of Academic
Development for Emory Winship Cancer Institute; Director, Emory Winship Cancer Institute
Cancer Chemoprevention Program
Dong Moon Shin, MD, FACP, serves the Emory Winship Cancer Institute as Professor of
Hematology and Oncology, and Otolaryngology; Associate Director of Academic Development
for Emory Winship Cancer Institute and Director of the Emory Winship Cancer
Chemoprevention Program.
Dr. Shin joined the Emory Winship Cancer Institute in 2003, when he moved from the
University of Pittsburgh Cancer Institute. Prior to joining the faculty in Pittsburgh, Dr. Shin
served as an associate professor of medicine at M.D. Anderson Cancer Center in Houston, TX.
Dr. Shin’s research focus is in head, neck and lung cancers. During the past 20 his research has
been in the following areas: Establishing carcinogenesis models in preclinical and clinical
settings for head, neck and lung cancer; developing biomarkers in animal and human
carcinogenesis for head, neck and lung cancer; developing molecular targeted prevention and
therapies using epidermal growth factor receptor (EGFR) signaling pathways (i.e., EGFR
monoclonal antibodies, EGFR tyrosine kinase inhibitors cyclooxygenase-2 (COX-2) inhibitors
and other molecular targeted molecules including green tea polyphenons; and developing novel
therapeutics (clinical or translational protocols) for head and neck cancer, lung cancer, thymoma
and mesothelioma. He is also currently focused on new drug delivery to cancer patients using
nanotechnology. Dr. Shin has published over 150 peer reviewed scientific articles in journals
such as The New England Journal of Medicine, The Journal of the National Cancer Institute,
Cancer Research, and The Journal of Clinical Oncology. Dr. Shin’s research is widely cited in
hundreds of studies and peer reviewed papers.
Dr. Shin earned his medical degree from Yonsei University, College of Medicine in Seoul,
Korea. He completed his internship and residency in Internal Medicine at Cook County
Hospital, Chicago, Illinois. He then completed a fellowship in Hematology and Medical
Oncology at the University of Texas M. D. Anderson Cancer Center, Houston. He is certified
by the American Board of Internal Medicine in Internal Medicine and Medical Oncology, and is
a Fellow of the American College of Physicians, a Fellow of the American Society of Head and
Neck Surgery, and an active member of the American Association for Cancer Research as well
as the American Society of Clinical Oncology. Dr. Shin is the recipient of numerous awards,
including being listed among America’s Best Doctors, Top Doctors in Cancer selected by
Atlanta Magazine, America’s Top Doctors for Cancer selected by Castle Connoly Medical
Ltd., and Marquis Who’s Who in the World. He is a Georgia Cancer Coalition
Distinguished Clinician Scientist Scholar and serves on the editorial boards of 6 journals
including Journal of Clinical Oncology, Clinical Cancer Research, American Journal of
Clinical Oncology. He has been the recipient of several competitive peer-reviewed grants
from American cancer Society, National Cancer Institute, and others over the last two
decades.